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Summary 
Theophylline crystallizes in the anhydrous or monohydrate form. The solubility of the anhydrous form exceeds the solubility of 
the monohydrate form below 60°C. The anhydrous: hydrate phase transition of theophylhne in buffered suspensions has been 
studied by measurement of the supersaturation profile and the crystal size djstributions. The role of c~stallographic parameters in 
the nucleation and growth of monohydrate crystals, during dissolution of the anhydrous phase, has been investigated. A 
solvent-mediated route has been identified and can be described in terms of the dissolution kinetics of the anhydrous phase and 
the nucleation and growth kinetics of the hydrated phase. The growth rate of the monohydrate crystals depends on the square of 
the supersaturation and is independent of the stirring rate. which suggests a surface-controlled growth process. The dissolution rate 
of the anhydrous crystals depends on the 1.5 order of the undersaturation and is inversely proportional to the square root of the 
crystal size. Anhydrous theophyIline crystals act as heterogeneous nucleation substrates for the crystals of the monohydrate phase 
and these grow epitaxiafly on the anhydrous crystals. Based on the kinetic equations for dissolution of the anhydrous form and 
crystallization of the monohydrate form, a computer simulation has been developed that predicts the changes in the concentration 
of theophylhne in solution during the phase transition. 
The presence of a metastable form during 
processing or in the final dosage form often leads 
to instability of drug release as a result of a phase 
transformation. Recent studies show erratic dis- 
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solution from anhydrous theophylline tablets 
stored at high relative humidities (Ando et al., 
1986; Herman et al., 1989) or prepared by a wet 
granulation process (Herman et al., 1988). These 
have been explained by a phase transformation 
from the anhydrous to the monohydrate form. 
TheophylIine is a widely used drug for the treat- 
ment of asthma. It has a pK, of 8.7 (Windholz, 
1983) and the solubility of the anhydrous form 
exceeds that of the monohydrate form, below 
60°C. 
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Anhydrous to hydrate phase transformations 
may occur by either of two processes, when the 
solid is in contact with water: (i) a solid-solid 
transformation in which water molecules are in- 
corporated into the crystal lattice while remaining 
in the solid state or (ii) a solvent-mediated pro- 
cess where the anhydrous solid dissolves, and 
creates the necessary supersaturation for the nu- 
cleation and growth of monohydrate crystals. 
It has been observed that during dissolution of 
anhydrous theophyIline from a disk (De Smidt et 
al., 1986) the monohydrate form crystallizes on 
the surface of the anhydrous form and that the 
transformation kinetics depends on the boundary 
layer thickness. Such observations suggest a sol- 
vent-mediated phase transformation. A critical 
question is whether heterogeneous nucleation and 
even epitaxy facilitate the birth and growth of 
crystals of the stable phase - if the presence of a 
metastable or unstable solid phase promotes nu- 
cleation, since spontaneous or homogeneous nu- 
cleation has not been observed. The surface of 
the anhydrous phase may act as a nucleation 
substrate for the monohydrate form by either 
decreasing the solution-nucleus interfacial energy 
or by a crystal lattice match. The latter would 
result in oriented, epitaxial, growth of the mono- 
hydrate crystals on the anhydrous phase. The 
higher the affinity of the solute for the solid 
substrate, the smaller the energy required to form 
the nucleus, and nucleation may occur at very low 
supersaturations (Walton, 1969). Thus, the theo- 
phylline concentration in solution may never 
reach the homogeneous nucleation levels. 
Previous studies (Wadke and Reier, 1972; 
Fokkens et al., 1983; De Smidt et al., 1986) em- 
phasize the consequences of a transformation, 
due to the crystallization of theophylline mono- 
hydrate, on the dissolution kinetics of anhydrous 
theophylline. However, the mechanisms and ki- 
netics by which theophylline monohydrate crys- 
tals nucleate and grow are not understood. The 
objective of this study was to elucidate the kinet- 
ics of the anhydrous to hydrate transformation of 
theophylline in a buffered suspension by taking 
into ~nsideration the dis~lution of the anhy- 
drous phase and the nucleation and growth of the 
monohydrate phase. The dissolution kinetics of 
anhydrous theophylline crystals and growth kinet- 
ics of monohydrate crystals have been reported 
(Wu, 1990; Rodriguez and Wu, 1991). In order to 
gain insight about the transformation mechanism, 
the concentration of theophylline in solution was 
monitored, and the evolution of the crystal size 
distribution (CSD) was measured. Furthermore, 
to investigate the importance of crystallographic 
parameters - the possibility of heterogeneous 
nucleation of monohydrate crystals and epitaxial 
growth on the anhydrous form - the transforma- 
tion was studied by microscopic observation. 
Materials and Methods 
Materials 
Anhydrous theophylline was obtained from 
Sigma Chemical Co. (St. Louis, MO), dried for 24 
h in an oven at 100°C and stored in a desiccator 
over calcium sulfate at room temperature. Large 
single crystals of anhydrous theophylline were 
grown from chloroform by slow evaporation, for 
microscopic studies. Theophylline monohydrate 
crystals were prepared by crystallization from 
phosphate buffer (pH 61, that was supersaturated 
by dissolving the anhydrous form. Monohydrate 
crystals were dried at room temperature and 
stored over a saturated solution of sodium bro- 
mide (relative humidity 60%). The water used in 
this study was filtered through a double-de- 
ionized purification system (Milli Q Water Sys- 
tem from Millipore Co.). Phosphate buffer (p1c-I 6) 
was prepared from 0.067 M potassium phosphate 
monobasic solution and 0.067 M sodium phos- 
phate dibasic solution, The ionic strength of the 
buffer was adjusted to 0.15 M with potassium 
chloride. These reagents were purchased from 
Aldrich Chemical Co. All solutions were filtered 
through a 0.45 pm filter prior to use. 
Assay and identification 
Theophylline concentration in solution was 
measured by UV spectrophotometry with a Beck- 
man DU-8 spectrophotometer at 270 nm. An IR 
s~troph~t~meter (Beckman IR-33) was used to 
determine the IR spectra of anhydrous and 
monohydrate theophylline crystals. Differential 
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scanning calorimetry (DSC) was performed with a 
DuPont 1090 Thermal Analyzer. 
~olubili~ 
The solubility of theophylline monohydrate was 
measured over the temperature range 8-4O“C, in 
0.067 M phosphate buffer (pH 61 of ionic strength 
0.15 M. Equilibrium was achieved by dissolution 
and c~stallization. 
The solubility of the anhydrous form was cal- 
culated from the initial dissolution rate of anhy- 
drous theophylline from a disk @hefter and 
Higuchi, 1963; Wadke and Reier, 1972). Anhy- 
drous or monohydrate crystals were compressed 
at a pressure of 3000 psi (Ib/inch2). The die was 
then piaced in a holder and lowered into the 
dissolution medium (400 ml of pH 6 buffer) that 
had been equilibrated at the desired tempera- 
ture. The solution was stirred with a magnetic 
stirrer and aliquots were taken at various times 
for analysis. 
Theophylline monohydrate seeds 
A saturated solution of theophylline monohy- 
drate in pH 6 phosphate buffer at 25°C was 
chilled in an ice bath (- 1O’U to 0°C with con- 
stant stirring. The suspension was filtered after 
the crystal seeds reached the desired size. The 
seeds were resuspended and aged in saturated 
buffer for a period of 2 weeks at room tempera- 
ture. The seeds were identified by IR spec- 
troscopy and the number per ml and CSD mea- 
sured. The seed suspension contained 76 mg 
monohydrate crystals per ml. 
Anhydrous to hydrate transformation 
Experiments were carried out with a suspen- 
sion of anhydrous theophyliine (250 ml) at 10°C 
in a 300 m1 jacketed beaker at a stirring rate of 
750 rpm. The initial concentration of the solution 
was adjusted to the solubility of the anhydrous 
form (8.75 mg/ml) prior to the addition of 5.5 g 
of anhydrous crystals. After a few seconds a sus- 
pension of monohydrate seed crystaIs was added. 
2-ml aliquots were taken, and the theophylline 
concentration in solution measured before and 
during the transformation. 
The concentration profiles were measured dur- 
ing the transformation and the effect of seeding 
with monohydrate theophylline crystals was inves- 
tigated. The transformation was carried out at 
monohydrate seed levels of 0%, 0.5% (38 mg) 
and 2.0% (152 mg). The concentration profile 
was also measured in the absence of anhydrous 
theophylline at a monohydrate seed level of 0.5%. 
The amount of monohydrate seeds is expressed 
as the percent weight of monohydrate theo- 
phylline crystals precipitated at the end of the 
process. 
The CSD was monitored as a function of time 
with an EIzone 18OXY particle counter (ParticIe 
Data Labs, Elmhurst, IL). Crystal sizes (volume 
equivalent size) within the range 12-120 pm were 
measured by using a 300 /*rn orifice size. After 
the transformation was completed the crystals 
were identified by IR spectroscopy to be the 
monohydrate form. 
In a separate series of experiments the dissolu- 
tion of anhydrous theophyiline and the growth of 
monohydrate crystals were studied. The dissolu- 
tion of anhydrous theophylline (50 mg) in pH 6 
phosphate buffer (200 ml) was evaluated at vari- 
ous undersaturations by monitoring the theo- 
phylline concentration and the CSD (Wu, 1989). 
A similar procedure was followed to study the 
crystallization kinetics of the monohydrate phase, 
and the growth rate dependence on supersatura- 
tion (Rodriguez and Wu, 19911. The driving force 
for dissoIution of the anhydrous phase is 
(1) 
where Sft is the solubility of anhydro~s theo- 
phyhine crystals, and C denotes the theophylline 
concentration in soIution. The driving force for 





where S, is the solubility of monohydrate theo- 
phylline crystals. 
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Single crystals of anhydrous theophyiline were 
added to a pH 6 solution saturated with respect 
to the anhydrous form at room temperature 
(25°C). Experiments were conducted in microti- 
tration multi-well plates of 0.35 ml capacity. The 
plate was placed on the stage of an inverted 
microscope (Nikon Diaphot) and the transforma- 
tion was followed by direct observation, Similar 
experiments were performed with the commer- 
cialIy prepared theophylline of a polyc~staIline 
nature (aggregated crystals). 
Results and Discussion 
Solubility 
During dissolution of anhydrous theophylline 
crystals, the solution becomes supersaturated with 
respect to the hydrated form which precipitates 
and grows until the concentration reaches the 
soiubility of the monohydrate modification. The 
m~imum value observed may correspond to the 
solubility of the anhydrous form or could be the 
result of a steady-state, dissolution-c~stallization 
process. 
A concentration-time profile resulting from 
disk dissolution of anhydrous and monohydrate 
modifications is presented in Fig. 1. These results 
suggest a transition during the dissolution of the 
anhydrous form. The rate of increase of theo- 
phylline concentration in the dissolution medium 
is faster during the first 6 min, then it becomes 
slower and parallels that of the monohydrate 
form. This indicates that during dissolution, the 
anhydrous theophylIine undergoes a phase transi- 
tion to the monohydrate form on the surface of 
the disk since there was no nucleation in the bulk 
of the solution. De Smidt and co-workers (1986) 
have confirmed the presence of theophylline 
monohydrate on the surface of anhydrous theo- 
phylline disks by IR spectroscopy and by micro- 
scopic observation. 
This transition may be the result of a solid-solid 
or solvent-mediated transformation. In the for- 
mer, the molecules rearrange themselves incorpo- 
rating the water of hydration into the crystal 




Fig. 1. Concentration profile during the dissolution of anhy- 
drous and monohydrate theophylline from a disk at 10°C. 
(- - - - - -) Dissolution rate of anhydrous theophylline. c-------J 
Dissolution rate of monohydrate theophylline. 
in the latter the anhydrous solid dissolves fol- 
lowed by c~stalli~ation of the monohydrate. Even 
though dissolution of the anhydrous (unstable) 
phase occurs in a solution where the bulk concen- 
tration of theophylline is below saturation with 
respect to the monohydrate (stable) phase, a sol- 
vent-mediated process is possible if the solvent 
adjacent to the disk surface is supersaturated. 
The solubility of the anhydrous form was eval- 
uated from the initial dissolution rate from a 
disk, while C -=z S,, according to (Shefter and 
Higuchi, 1963): 
This expression is valid because the dissolution 
rate constant is proportional to the diffusion co- 
efficient, the boundary layer thickness and the 
surface area. Under constant hydrodynamic con- 
ditions and equal surface areas, both crystal forms 
should have the same value of the dissolution 
rate constant. The solubility curves for the anhy- 
drous and monohydrate modification are pre- 
sented in Fig. 2. 
anhydrous I 
0 10 20 30 40 50 
Tempfwature (“C) 
Fig. 2. Solubility dependence on temperature, for anhydrous 
and monohydrate theophylhne in pH 6 phosphate buffer. 
Points a and b represent the concentration range in which 
the phase transformation was studied. 
Phase transformation 
The anhydrous-monohydrate phase transition 
of theophylline was studied in a suspension at 
140, 1401 
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10°C. At this temperature the solubility of the 
anhydrous form is 8.75 mg/ml whereas that of 
the monohydrate has a value of 2.99 mg/ml. 
Initially, anhydrous theophylline crystals were 
suspended in a solution of composition a (Fig. 2) 
which corresponds to the solubility of the anhy- 
drous form. The transformation was completed at 
point b, when the solubility of the monohydrate 
form was reached. 
Fig. 3 shows the CSDs measured during the 
transformation of 5.5 g of anhydrous theophylline 
and 0.5% monohydrate seeds. The amount of 
monohydrate seeds is expressed as % (w/w) of 
the final mass of theophylline monohydrate pre- 
cipitated. Several comments can be made about 
the distributions: (a) there is significant dissolu- 
tion of the anhydrous crystals after 2 min, as 
shown by the decrease in the number of large 
anhydrous crystals (plot C); (b) growth of the 
monohydrate seeds is negligible in depleting the 
supersaturation and (c) a large number of mono- 
hydrate crystals nucleated and have grown to an 
average size of 25 pm, after 6 min. These obser- 
B 
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Fig. 3. CSD during the transformation of 5.5 g anhydrous theophylline in the presence of 0.5% monohydrate seeds. Initial 
distributions of monohydrate seeds (A) and anhydrous phase (B). Distributions during the transformation, at 2 min (0, 4 min (D) 
and 6 min (E). The samples were diluted 200 X in panels B-E. 
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vations confirm the process to be a solvent-medi- 
ated phase transformation rather than a solid- 
state hydration promoted by the solvent. If a 
solid-state mechanism were responsible for the 
transformation, the shape of the CSD would have 
been conserved. 
The magnitude of the nucleation event is best 
seen by comparing the final number of theo- 
phylline monohydrate crystals as a function of the 
initial amount of anhydrous crystals, and the ini- 
tial amount of monohydrate crystal seeds in Fig. 
4. The final number of monohydrate crystals is 
strongly dependent on the amount of anhydrous 
phase present which indicates a heterogeneous 
nucleation mechanism. The presence of theo- 
phylline monohydrate crystals does not promote 
nucleation (secondary nucleation) since the final 
number o%crystals is not dependent on the initial 
number of’monohydrate crystal seeds. 
Typical curves showing the variation in con- 
centration as a function of time for solutions 
having ‘initially the same amount of anhydrous 
theophylline crystals and supersaturation with re- 
spect to monohydrate, but different amounts of 
monohydrate seeds, are shown in Fig. 5. The 
curves usually consist of three stages. In the first 
5.5 g anhydrous 
2.6x1( 6.4~10' 0 0 0 6.4xlC 
Number of monohydrate seeds 
Fig. 4. Variation of the final number of hydrated theophylline 
crystals with the number of monohydrate seeds and mass of 
anhydrous phase added. A seed level of 0.5% corresponds to 
a number of crystals of 6.4 x lo6 and 2.0% to 2.6 X 10’. 
Monohydrate seeds 1 
l 0.0% 2.0 - 
= n 0.5% 
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Fig. 5. Concentration profile during the transformation of 5.5 
g of anhydrous theophylline in the presence of various levels 
of monohydrate seeds. 
stage, the concentration remains constant for 
some time, so that the curves exhibit a plateau 
whose length depends on the initial amount of 
monohydrate seeds. Dissolution of anhydrous 
crystals is very slow because the solution is weakly 
undersaturated. Microscopic observation of the 
solid phase shows that this stage corresponds to 
the heterogeneous nucleation of monohydrate 
crystals. As the amount of monohydrate crystal 
seeds increased the length of the plateau de- 
creased due to a larger surface area available for 
growth initially, whereas the final number of crys- 
tals remained constant. In the second stage, the 
theophylline concentration in solution decreases 
very rapidly, and the desupersaturation rate is 
independent of the number of monohydrate crys- 
tal seeds. This stage corresponds to nucleation 
and growth of theophylline monohydrate. Disso- 
lution of the anhydrous form cannot compensate 
for the monohydrate crystallization. The super- 
saturation-time profile during monohydrate crys- 
tal growth in the absence of anhydrous phase is 
shown in Fig. 6. Nucleation is negligible and 
growth is mainly responsible for the decay in the 
supersaturation. In the last stage monohydrate 
crystals grow at a very low supersaturation and 
the concentration approaches the solubility of the 
monohydrate form. After describing the main 
stages of the anhydrous-hydrate transformation 
of theophylline in suspension, we consider in 
more detail the processes involved. 
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Anhydrous d~solut~on 
The dissoiution rate of anhydrous theophylline 
crystals as a function of solution undersaturation 
under conditions similar to those encountered 
during the phase transformation experiments was 
measured. These experiments were carried out 
with a constant initial amount of anhydrous theo- 
phylline, at various degrees of undersaturation, 
CQ. To avoid correcting for a change in shape 
factor during dissolution, only the initial dissolu- 
tion rates were considered. The dissolution rate, 
D, was found to be size dependent, viz., the 
smaller crystals dissoIved at a faster rate than the 
Iarger ones. The results are described by: 
D = k,o,“L’ (4) B 
where k,, the dissolution rate constant, has a 
value of 500, the reaction order, m, has a value of 
1.5, L represents the crystal volume diameter and 
the exponent b has a value of -0.5. The reaction 
order with respect to undersaturation for other 
systems (Amathieu and Boistelie, 1988) has been 
found to be in the range of one to two. A reac- 
tion order of one is taken to indicate that the 
rate-determining step is volume diffusion while 
for interfacial control the reaction order is two. 
The intermediate value obtained in this case may 
be due to the fact that heterogeneous nucleation 
on the anhydrous crystals disturbs the surface 
7 
Monohyd~te seeds 
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Fig. 6. ~ncentration profile during c~stal~ization of theo- 
phylline monohydrate in the presence (----- ) and absence 
(- - - - - -1 of anhydrous theophylline. 
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Fig. 7. Dependence of anhydrous theophylline dissolution rate 
and monohydrate growth rate on the driving force, o, at 10°C. 
phenomena, since the solutions are Supersatu- 
rated with respect to the monohydrate modifica- 
tion, 
Growth of munohydrate crystals 
The growth of theophylline monohydrate crys- 
tals has been studied as a function of the super- 
saturation (Rodriguez and Wu, 1991). In Fig. 7 
the growth rate is plotted as a function of the 
supersaturation according to the linearized form 
of 
G = k,u;; 
where the growth rate constant, k,, has a value of 
5.5, and the growth exponent, n, has a value of 
2.2 for supersaturations below 0.85. This result is 
in agreement with the screw dislocation model. In 
this case, the growth rate can change linearly or 
parabolically with respect to the supersaturation 
(Burton et al., 1951). At higher supersaturations, 
n = 1.5 which may indicate a higher step density, 
where attachment of molecules to a step directly 
from the supersaturated phase is more probable 
than surface diffusion. It was also observed that 
the growth of theophyliine monohydrate crystals 
is independent of the stirring rate and from the 
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temperature dependence of the growth rate, the 
activation energy for crystal growth was deter- 
mined to be 14.3 kcal/mol. 
Fig. 7 illustrates the influence of the driving 
force upon dissolution of anhydrous and crystal- 
lization of monohydrate theophylline. At the same 
departure from equilibrium, chemical potential, 
ApD = AkG or u A = in, dissolution proceeds at a 
faster rate than crystallization. The energy of 
activation for diffusion determined from the tem- 
perature dependence of the dissolution rate of 
theophylline from a disk was 4.4 kcal/mol (Wu, 
1990). This confirms that growth of the monohy- 
drate form is controlled by a surface reaction 
mechanism rather than by solute diffusion in the 
bulk. When dissolution data from a rotating disk 
are used to investigate a phase transformation, it 
is important to establish the rate-determining 
step. Interpretations can be misleading, since 
crystal growth has been frequently assumed to be 
diffusion-controlled. 
Heterogeneous nucleation and epitaxy 
To identify the crystallographic consequences 
on the heterogeneous nucleation mechanism, ex- 
periments have been carried out with single crys- 
tals and polycrystalline samples of anhydrous 
theophylline in contact with a solution saturated 
with respect to the anhydrous form. Through 
microscopic observation the following events were 
noticeable. The polycrystalline samples and single 
crystals of anhydrous theophylline were, within 
minutes, covered by crystallites of the hydrated 
phase as shown in Fig. 8a. The monohydrate 
crystals grew towards the solution while the anhy- 
drous phase slowly dissolved (Fig. 8b). Towards 
Fig. 8. Photographs displaying the heterogeneous nucleation of theophylline monohydrate on the surface of polycrystalline 
theophylline anhydrous, in contact with phosphate buffer saturated with respect to the anhydrous phase at 25°C: (a) 2 min and (b) 
24 h. 
Fig. 8b. 
the end of the process traces of anhydrous crys- 
tals remained on the hydrated phase. Eventually 
(24 h) all the anhydrous phase dissolved. In the 
case of the polycrystalline sample, the hydrated 
crystals were randomly oriented on the anhydrous 
surface which hindered their dissolution. When 
anhydrous single crystals were used as the nucle- 
ating substrate, the monohydrate crystals grew 
aligned along the principal face of the anhydrous 
crystal as is illustrated in Fig. 9. The direction of 
fast growth of the monohydrate, b crystallo- 
graphic axis (Sutor, 1958), is superimposed on the 
direction of elongation of the anhydrous crystal, 
b crystallographic axis. From the unit cell dimen- 
sions (Table 11, a lattice match along the b axis is 
the most likely one. This confirms the epitaxial 
mechanism observed, as a result of a template- 
mediated nucleation. Fig. 9 portrays the crystallo- 
graphic plate (OlO), which shows the molecular 
arrangement of theophylline monohydrate along 
its b crystallographic axis. 
Previous studies on the phase transitions of 
calcium sulfate hydrates (Amathieu and Boistelle, 
1988), and hydrated and anhydrous uric acid 
(Boistelle and Rinaudo, 1981) have shown that 
heterogeneous nucleation occurs on the surface 
of the unstable phase. Each uric acid modifica- 
tion epitaxially grows on the other one and this 
has been explained by a crystallographic mecha- 
nism. 
Simulation of the concentration profile’ during the 
phase transformation 
Insight into the mechanisms and kinetics of 
the solution-mediated phase transformation of 
theophylline has been provided, by studying the 
dissolution kinetics of the anhydrous form as well 
as the crystallization kinetics of the monohydrate 
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TABLE 1 
















a Sutor (19.58). 
’ Naqvi and Bhattacharyya (1981). 
phase. One of our objectives was to explain the 
behavior of the system by taking into account the 
above-mentioned processes. Since the change in 
concentration of theophylline in solution ac- 
counts for both crystallization and dissolution, its 
assessment was chosen as a representative pa- 
rameter to describe the kinetics of the system. 
The question is, how does the phase-transforma- 
tion kinetics lead to the measured theophylline 
concentration profile in solution? 
This system can be described as an isothermal, 
triphasic, closed system, comprised of two solid 
phases, anhydrous and monohydrate theo- 
phylline, and one liquid phase, theophylline in 
solution (the different forms in which theo- 
phylline can exist in solution need not be consid- 
ered for the following treatment). As described in 
Materials and Methods, the system, which is agi- 
tated at constant angular velocity, is adjusted to 
have an initial concentration of theophylline suf- 
ficient to achieve the solubility of the anhydrous 
form, yielding a metastable solution with respect 
to the monohydrate form. A given amount of 
both anhydrous and monohydrate crystals of 
known size distributions is added, inducing the 
Fig. 9. (a) Theophylline monohydrate, needle-like crystals, growing on’the surface of theophylline anhydrous, plate-like single 





formation of monohydrate solid phase and the 
concomitant dissolution of the anhydrous form. 
Crystallization of monohydrat~ theophylline con- 
tributes to the depletion of theophylline in solu- 
tion, due to growth of monohydrate seeds and 
heterogeneous nucleation and growth of monohy- 
drate crystals. Dissolution of the anhydrous form 
increases the concentration of theophylline in 
solution. The observed effect is that the theo- 
phylline concentration remains constant as long 
as the dissolution of the anhydrous solid form 
keeps up with the precipitation of the monohy- 
drate form. Once all the anhydrous form has 
dissolved, the growth rate of the monohydrate 
crystals causes a rapid decrease of theophyihne in 
solution. Finally, the theophyhine concentration 
in solution approaches the so~ubility of the mono- 
hydrate crystals and the transfo~ation is com- 
pleted. 
The value of the instantaneous concentration 
dictates, in turn, both the degree of supersatura- 
tion with respect to monohydrate, @n, and the 
degree of undersaturation with respect to the 
anhydrous form, aA, driving forces for crystalliza- 
tion and for dissolution, respectively. The kinetic 
equations that describe the anhydrous phase dis- 
soIution (Eqn 4) and the monohydrate phase 
growth (Eqn 5) are both a function of u, but 
while the growth rate is independent of the crys- 
tal size the dissolution rate is not. These rate 
equations represent average values determined 
from a given sampIe of crystals of different sizes. 
They have been used to simulate the evolution of 
the CSD during the transformation. The amount 
and the number of crystals vs size of the monohy- 
drate seeds and the anhydrous crystals are mea- 
sured at the beginning of an experiment. The 
CSD on a number basis of the monohydrate 
nuclei formed during the transformation is evaiu- 
ated from the final CSD, when the transforma- 
tion is completed, by taking into account the 
seeds added initially and the diameter to which 
they grew during the transformation. The nucle- 
ation event is assumed to occur as a burst of 
monohydrate crystals after the observed lag time 
in the concentration profile. The narrow spread 
in size (age) of the measured CSDs supports the 
validi~ of this assumption. If nucleation occurred 
over a large supersaturation range, or time range, 
the resulting CSD would exhibit a large size 
spread (standard deviation), since crystal growth 
is not size dependent. 
A computer program was written in FOR- 
TRAN 77, according to the above description of 
the system, following the scheme: 
(1) Input the initial theophylline concentration 
in solution, C,, and the initial crystal size distri- 
bution per unit volume given by the number 
density functions, n,(L,), for the anhydrous, 
monohydrate seeds and monohydrate nuclei. 
(2) Calculate the total mass of the anhydrous 
seeds, monohydrate seeds and monohydrate nu- 
clei in suspension per unit volume (slurry density, 
M), for each of the solid phases: 
M AJ1.N = “VP b,,( L,)L:AL (6) 
where cy, is the volume shape factor, p denotes 
the crystal density, and AL represents the size 
interval. 
(3) Calculate and save the values of the con- 
centration of theophylline in solution by means of 
a mass balance, using the previous result to calcu- 
late how much theophylline has been dissolved 
and how much theophylline has been precipi- 
tated, i.e.: 
C(t)=C”+C,,-C”-C, (7) 
where C(t) denotes the instantaneous concentra- 
tion of theophylline in solution, C, is the concen- 
tration of the anhydrous form dissolved in At, 
calculated from the difference of the initial 
amount of the anhydrous seeds minus the amount 
of the anhydrous seeds from step 2, M,,; C,, + C, 
corresponds to the concentration of theophylline 
depleted by crystallization and is also obtained by 
difference of the amount of monohydrate calcu- 
lated in step 2, M,, minus the initial amount of 
monohydrate in suspension plus the amount of 
monohydrate formed due to nuclei growth, MN. 
(4) Calculate the magnitude of the driving force 
for dissolution, a,, and for crystallization, (J,,, 
from Eqns 1 and 2. 
(5) Calculate the instantaneous growth rate: 
G(r) = k,u; (8) 

























Fig. IO. Observed and predicted concentration profiles. 
(6) Calculate the instantaneous dissolution 
rate: 
D(r); = k&Y,‘: 
where k, = 500, h = -0.5, and m = 1.5. 
(7) Calculate new crystal sizes: 
(9) 
L,=Li_, -D(t),_, At (anhydrous form) 
(IO) 
L, = Lj_, + G(t) At (monohydrate) (II) 
(8) Assign the new sizes to the old values in 
the number density function to obtain the new 
size distributions for all the solid phases: anhy- 
drous seeds, monohydrate seeds and monohy- 
drate nuclei: 
“(Lj-,) =n(L;) (12) 
(9) Repeat steps 2-8 and stop when Lj = 0 for 
the anhydrous form and Li = L,_, for the mono- 
hydrate solid phase. 
The results of the simulation are shown in Fig. 
10. 
Conclusions 
The results of the present study show that the 
anhydrous to hydrate transformation of theo- 
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phylline occurs by a solvent-mediated process. 
Insight into the mechanisms responsible for the 
transformation is provided, by measuring the con- 
centration profile and the evolution of the CSD 
during the phase transformation, By indepen- 
dently studying the processes involved, dissolu- 
tion and crystallization, the transformation kinet- 
ics has been described. 
Anhydrous theophylline crystals act as hetero- 
geneous nucleation substrates for the crystals of 
the monohydrate form and the new phase grows 
epitaxially on the anhydrous crystals. This has 
significant consequences on the choice of a 
metastable or a stable solid phase of a drug in a 
formulation, since it is frequently assumed that 
the metastable phase would dissolve faster. How- 
ever, if the metastable phase is a heterogeneous 
nucleant for the stable phase, the dissolution of 
the metastable phase will be inhibited, and the 
anticipated drug concentration levels will not be 
achieved. This explains the observed instability of 
drug release from anhydrous theophytline dosage 
forms. 
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